Cigna Investments’s ICL Group ICL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69K Hold
13,682
0.01% 478
2026
Q1
$70K Hold
13,682
0.01% 453
2025
Q4
$79K Hold
13,682
0.01% 458
2025
Q3
$86K Hold
13,682
0.01% 468
2025
Q2
$94K Hold
13,682
0.02% 449
2025
Q1
$77K Sell
13,682
-2,761
-17% -$16.2K 0.01% 439
2024
Q4
$81K Hold
16,443
0.01% 455
2024
Q3
$70K Hold
16,443
0.01% 466
2024
Q2
$71K Hold
16,443
0.01% 443
2024
Q1
$87K Buy
16,443
+3,057
+23% +$15K 0.02% 456
2023
Q4
$68K Hold
13,386
0.01% 438
2023
Q3
$74K Hold
13,386
0.02% 417
2023
Q2
$73K Hold
13,386
0.01% 454
2023
Q1
$90K Hold
13,386
0.02% 448
2022
Q4
$96K Hold
13,386
0.02% 444
2022
Q3
$109K Hold
13,386
0.02% 422
2022
Q2
$121K Hold
13,386
0.02% 446
2022
Q1
$161K Buy
13,386
+2,936
+28% +$31.1K 0.02% 581
2021
Q4
$101K Hold
10,450
0.01% 645
2021
Q3
$77K Hold
10,450
0.01% 730
2021
Q2
$71K Hold
10,450
0.01% 744
2021
Q1
$61K Sell
10,450
-321
-3% -$1.82K ﹤0.01% 765
2020
Q4
$55K Buy
+10,771
New +$45K ﹤0.01% 730

Other funds holding ICL

Cigna Investments's ICL Position: Q2 2026 in Review

Cigna Investments held its ICL Group (ICL) position steady in Q2 2026 at 13,682 shares worth $69K. The position accounts for 0.01% of the portfolio, ranked #478.

Cigna Investments first reported a position in ICL in Q4 2020 and has held it in 23 quarters since. The position peaked at $161K in Q1 2022. 220 funds tracked by Wall St. Rank hold ICL as of Q2 2026.

  • Cigna Investments held 13,682 shares of ICL Group worth $69K as of Q2 2026.
  • Cigna Investments left its ICL Group share count unchanged in Q2 2026.
  • ICL Group made up 0.01% of Cigna Investments's portfolio in Q2 2026, its #478 holding.
  • Cigna Investments first reported a position in ICL Group in Q4 2020 and has held it in 23 quarters since.
  • Cigna Investments's ICL Group position peaked at $161K in Q1 2022.
  • 220 funds tracked by Wall St. Rank held ICL Group as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.